Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Via Parea, 4, 20138, Milan, Italy.
Albert Einstein College of Medicine, Montefiore Hospital, Bronx, NY, USA.
J Interv Card Electrophysiol. 2020 Mar;57(2):241-249. doi: 10.1007/s10840-019-00587-y. Epub 2019 Jul 16.
Since the introduction of catheter ablation as a mainstream treatment for atrial fibrillation (AF), several technical improvements have been put forward. In this contest, Ablation Index (AI) is an accurate ablation quality marker by incorporating power, delivery time, contact force (CF), and catheter stability in a weighted formula. The aim of our study is to evaluate the efficacy of AI-guided AF ablation over 24 month follow-up.
We evaluated 72 consecutive patients with drug-refractory paroxysmal (66.7%) and early-persistent AF (33.3%) undergoing AI-guided ablation, compared to 72 propensity-matched control patients who underwent CF-guided procedure. All procedures were performed by three skilled operators. Data concerning procedural characteristics and long-term freedom from AF recurrence were analyzed.
At 24-month follow-up, Kaplan-Meier curves of AF recurrence were significantly lower in AI group than in CF group (15.5% vs. 30.6%; p 0.042). These findings were confirmed in a sub analysis regardless of the continued use of antiarrhythmic drugs in the follow-up (42.2% in AI-guided group and 66.7% in CF-guided group, p 0.004). At 24-month follow-up, a positive trend in the decrease of arrhythmia recurrences was observed in AI-guided ablation for all operators.
AI-guided ablation results more effective than CF-guided ablation as demonstrated by a lower incidence of AF recurrences regardless of the use of antiarrhythmic drugs in the follow-up. Each operator seems to improve the long-term success using an AI-guided ablation, thus showing both the efficacy and the reproducibility of this approach.
自导管消融作为治疗心房颤动(AF)的主流方法引入以来,已经提出了几种技术改进。在这一竞争中,消融指数(AI)是一种通过在加权公式中纳入功率、输送时间、接触力(CF)和导管稳定性的精确消融质量标志物。我们的研究旨在评估 AI 指导的 AF 消融在 24 个月随访中的疗效。
我们评估了 72 例药物难治性阵发性(66.7%)和早期持续性 AF(33.3%)接受 AI 指导消融的连续患者,与 72 例接受 CF 指导程序的倾向匹配对照患者进行比较。所有程序均由三名熟练的操作员进行。分析了与程序特征和长期无 AF 复发相关的数据。
在 24 个月的随访中,AI 组的 AF 复发 Kaplan-Meier 曲线明显低于 CF 组(15.5%比 30.6%;p=0.042)。在亚分析中,无论在随访中是否继续使用抗心律失常药物,均证实了这一发现(AI 指导组为 42.2%,CF 指导组为 66.7%,p=0.004)。在 24 个月的随访中,AI 指导消融的心律失常复发率呈下降趋势。
AI 指导消融的效果优于 CF 指导消融,表现为无论在随访中是否使用抗心律失常药物,AF 复发的发生率均较低。每个操作员似乎都通过 AI 指导消融提高了长期成功率,从而显示了这种方法的疗效和可重复性。